JP2015537010A5 - - Google Patents

Download PDF

Info

Publication number
JP2015537010A5
JP2015537010A5 JP2015542134A JP2015542134A JP2015537010A5 JP 2015537010 A5 JP2015537010 A5 JP 2015537010A5 JP 2015542134 A JP2015542134 A JP 2015542134A JP 2015542134 A JP2015542134 A JP 2015542134A JP 2015537010 A5 JP2015537010 A5 JP 2015537010A5
Authority
JP
Japan
Prior art keywords
methyl
oxy
ethyl
purine
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015542134A
Other languages
English (en)
Japanese (ja)
Other versions
JP6297582B2 (ja
JP2015537010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2013/001394 external-priority patent/WO2014075392A1/en
Publication of JP2015537010A publication Critical patent/JP2015537010A/ja
Publication of JP2015537010A5 publication Critical patent/JP2015537010A5/ja
Application granted granted Critical
Publication of JP6297582B2 publication Critical patent/JP6297582B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015542134A 2012-11-16 2013-11-15 ヒトホスファチジルイノシトール3−キナーゼデルタのプリン阻害剤 Expired - Fee Related JP6297582B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261727416P 2012-11-16 2012-11-16
US61/727,416 2012-11-16
PCT/CN2013/001394 WO2014075392A1 (en) 2012-11-16 2013-11-15 Purine inhibitors of human phosphatidylinositol 3-kinase delta

Publications (3)

Publication Number Publication Date
JP2015537010A JP2015537010A (ja) 2015-12-24
JP2015537010A5 true JP2015537010A5 (pt-PT) 2016-12-22
JP6297582B2 JP6297582B2 (ja) 2018-03-20

Family

ID=50730541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015542134A Expired - Fee Related JP6297582B2 (ja) 2012-11-16 2013-11-15 ヒトホスファチジルイノシトール3−キナーゼデルタのプリン阻害剤

Country Status (11)

Country Link
US (1) US9730940B2 (pt-PT)
EP (1) EP2920171B1 (pt-PT)
JP (1) JP6297582B2 (pt-PT)
KR (1) KR20150082613A (pt-PT)
CN (1) CN104918939B (pt-PT)
AU (1) AU2013347538B2 (pt-PT)
BR (1) BR112015011148A8 (pt-PT)
CA (1) CA2891009A1 (pt-PT)
MX (1) MX2015006191A (pt-PT)
RU (1) RU2658006C2 (pt-PT)
WO (1) WO2014075392A1 (pt-PT)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途
TN2016000227A1 (fr) 2013-12-05 2017-10-06 Pfizer Pyrrolo[2,3-d]pyrimidinyle, pyrrolo[2,3-b]pyrazinyle et pyrollo[2,3-d]pyridinyle acrylamides.
EP3115362B1 (en) 2014-03-06 2019-06-12 Shanghai Haiyan Pharmaceutical Technology Co. Ltd. Piperidine derivatives as orexin receptor antagonist
CN104030998B (zh) * 2014-06-05 2015-11-18 华东师范大学 4-多氟烷基-4,5-二取代异噁唑衍生物及其制备方法
WO2016020784A1 (en) 2014-08-05 2016-02-11 Pfizer Inc. N-acylpyrrolidine ether tropomyosin-related kinase inhibitors
KR102455043B1 (ko) 2014-09-11 2022-10-13 얀센 파마슈티카 엔.브이. 치환된 2-아자바이사이클 및 오렉신 수용체 조절제로서의 이의 용도
EP3204379B1 (en) * 2014-10-10 2019-03-06 Genentech, Inc. Pyrrolidine amide compounds as histone demethylase inhibitors
US10189844B2 (en) 2016-02-04 2019-01-29 Chiesi Farmaceutici S.P.A. Pyrazole derivatives as phosphoinositide 3-kinases inhibitors
WO2017166104A1 (en) * 2016-03-30 2017-10-05 Merck Sharp & Dohme Corp. Purine inhibitors of human phosphatidylinositol 3-kinase delta
KR102493644B1 (ko) * 2016-09-14 2023-01-30 얀센 파마슈티카 엔.브이. 메닌-mll 상호작용의 스피로 바이사이클릭 억제제
US10494370B2 (en) 2017-08-16 2019-12-03 Bristol-Myers Squibb Company Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
CN113620976B (zh) * 2020-05-09 2023-09-26 中国医学科学院药物研究所 噻唑并嘧啶类化合物及其制备方法、用途和药物组合物
JPWO2022209916A1 (pt-PT) * 2021-03-29 2022-10-06
CN113072480B (zh) * 2021-04-13 2022-09-30 常州佳德医药科技有限公司 一种手性(-)-5-氮杂螺[2.4]庚烷-7-醇、制备方法及应用
WO2024083237A1 (en) * 2022-10-20 2024-04-25 Impact Therapeutics (Shanghai) , Inc Substituted heteroaryl bicyclic compounds as usp1 inhibitors and the use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95516A (pt) * 1989-10-06 1991-08-14 Wellcome Found Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos
US5670501A (en) 1994-09-01 1997-09-23 Discovery Therapeutics, Inc. N-substituted 9-alkyladenines
DK1278748T3 (da) 2000-04-25 2011-04-18 Icos Corp Inhibitorer af human phosphatidyl-inositol 3-kinase delta
AU8294101A (en) * 2000-07-21 2002-02-05 Gilead Sciences Inc Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
SE0300456D0 (sv) * 2003-02-19 2003-02-19 Astrazeneca Ab Novel compounds
JP2006527213A (ja) * 2003-06-12 2006-11-30 ノボ ノルディスク アクティーゼルスカブ ホルモン感受性リパーゼの阻害剤として使用するための、置換ピペリジンカルバメート
CA2565037A1 (en) 2004-04-28 2005-11-10 Cv Therapeutics, Inc. Purine derivatives as a1 adenosine receptor antagonists
US8008307B2 (en) * 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
MY157177A (en) * 2006-08-08 2016-05-13 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of e1 activating enzymes
AU2009269087A1 (en) 2008-07-07 2010-01-14 Xcovery Holding Company Llc PI3K isoform selective inhibitors
WO2011075643A1 (en) * 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
EP2588473A1 (en) 2010-06-30 2013-05-08 Amgen Inc. Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors
UA112517C2 (uk) * 2010-07-06 2016-09-26 Новартіс Аг Тетрагідропіридопіримідинові похідні
WO2012037204A1 (en) 2010-09-14 2012-03-22 Exelixis, Inc. Inhibitors of pi3k-delta and methods of their use and manufacture
ES2612503T3 (es) * 2010-09-14 2017-05-17 Exelixis, Inc. Compuestos 9H-purina como inhibidores de PI3K-delta y métodos para su preparación
CN102838600A (zh) * 2011-06-24 2012-12-26 山东亨利医药科技有限责任公司 苯基喹唑啉类PI3Kδ抑制剂

Similar Documents

Publication Publication Date Title
JP2015537010A5 (pt-PT)
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
JP7418395B2 (ja) Shp2ホスファターゼ阻害剤およびこれらの使用方法
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
RU2716136C2 (ru) Бициклические лактамы и способы их применения
RU2015122894A (ru) Пуриновые ингибиторы фосфатидилинозитол-3-киназы дельта человека
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
JP2015522002A5 (pt-PT)
JP2016502522A5 (pt-PT)
EP3630770A1 (en) Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
HRP20120105T1 (hr) Aminoheterociklički spojevi
JP2014506929A5 (pt-PT)
HRP20170285T1 (hr) Heterociklilamini kao inhibitori pi3k
JP2021506941A5 (pt-PT)
JP2017505327A5 (pt-PT)
JP2015527399A5 (pt-PT)
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
RU2014123316A (ru) Ингибиторы фосфодиэстеразы типа 10а
RU2020129785A (ru) Фармацевтические производные 6,5-гетеробициклического кольца
JP2015504057A5 (pt-PT)
JPWO2019191229A5 (pt-PT)
JPWO2020005877A5 (pt-PT)
JP2021504380A5 (pt-PT)
TW202132297A (zh) 經取代吡啶及使用方法